Difference between revisions of "Part:BBa K4361103"

Line 3: Line 3:
 
<partinfo>BBa_K4361103 short</partinfo>
 
<partinfo>BBa_K4361103 short</partinfo>
  
BlcR is a transcription factor originating from the bacterium <i>Agrobacterium tumefaciens</i>. A single BlcR monomer contains an effector binding domain near the C-terminus which recognizes the effectors, succinic semialdehyde (SSA) and gamma-Butyrolactone GBL, but also the rape drug gamma-hydroxybutyric acid (GHB). The N-terminal region allows for the dimerization of two BlcR monomers. Dimeric BlcR can bind to the <i> blc <i/> operator sequence. <br>  
+
BlcR is a transcription factor originating from the bacterium <i>Agrobacterium tumefaciens</i>. A single BlcR monomer contains an effector binding domain near the C-terminus which recognizes the effectors, succinic semialdehyde (SSA) and gamma-Butyrolactone GBL, but also the rape drug gamma-hydroxybutyric acid (GHB). The N-terminal region allows for the dimerization of two BlcR monomers. Dimeric BlcR can bind to the <i> blc </i> operator sequence. <br>  
 
BlcR was originally added to the Parts Registry as [[Part:BBa_K1758370]] by the Bielefeld-CeBiTec iGEM 2015 team. Their sequence for BlcR has been codon optimized for expression in <i>E.coli</i> by us to improve expression of the protein ([[Part:BBa_K4361100]]). This composite part consists of codon-optimized BlcR, a 6xHis-tag for purification [[Part:BBa_K4361102]], and a TEV cleavage site for removal of the tag from the protein ([[Part:BBa_K4361102]]). With this composite part, we were able to effectively produce and purify BlcR in <i> E. coli </i>.  
 
BlcR was originally added to the Parts Registry as [[Part:BBa_K1758370]] by the Bielefeld-CeBiTec iGEM 2015 team. Their sequence for BlcR has been codon optimized for expression in <i>E.coli</i> by us to improve expression of the protein ([[Part:BBa_K4361100]]). This composite part consists of codon-optimized BlcR, a 6xHis-tag for purification [[Part:BBa_K4361102]], and a TEV cleavage site for removal of the tag from the protein ([[Part:BBa_K4361102]]). With this composite part, we were able to effectively produce and purify BlcR in <i> E. coli </i>.  
  
Line 28: Line 28:
 
<html>
 
<html>
 
<h3>Experimental results</h3>
 
<h3>Experimental results</h3>
<a href='https://2022.igem.wiki/tudelft/notebook#section2'>Wet Lab module 1</a>focused on optimizing the expression and purification of BlcR. After applying the <a https://2022.igem.wiki/tudelft/engineering>engineering cycle</a> multiple times, a protocol was developed which allowed for effective protein production and purification. After expression in <i>E. coli</i> BL21(DE3) cells, the protein was purified with Ni-NTA column purification, and gel filtration.  
+
<a href='https://2022.igem.wiki/tudelft/notebook#section2'>Wet Lab module 1</a> focused on optimizing the expression and purification of BlcR. After applying the <a https://2022.igem.wiki/tudelft/engineering>engineering cycle</a> multiple times, a protocol was developed which allowed for effective protein production and purification. After expression in <i>E. coli</i> BL21(DE3) cells, the protein was purified with Ni-NTA column purification and gel filtration.
 +
<br>
 +
We were able to obtain a highly pure and concentrated (36.1 µM) BlcR sample after executing our optimized production and purification <a https://2022.igem.wiki/tudelft/protocols</a>(<b>Figure 2</b>).  
  
 +
 +
<figure>
 +
<a href="https://static.igem.wiki/teams/4361/wiki/part-pages/label-gel.png"><img src="https://static.igem.wiki/teams/4361/wiki/part-pages/label-gel.png" style="width:500px;margin-left:175px"></a>
 +
<figcaption> <b>Figure 2.</b> SDS PAGE of different elution fractions after size exclusion with BlcR protein sample. Protein bands corresponding to the monomer (~35 kDa) and dimer (~70 kDa) of BlcR are visible. </figcaption>
 +
</figure>
  
  
 
</p>
 
</p>
 
<p>
 
<p>
The functionality of this part was later proven in experiments with the BlcR-binding DNA oligos, see </html>[[Part:BBa_K4361000]] through [[Part:BBa_K4361022]]<html> and <a href='https://2022.igem.wiki/tudelft/results#section4'>our results for module 3</a>.
+
To characterize the binding of BlcR to its cognate DNA binding sequence [[Part:BBa_K4361000]], we used electrophoresis mobility assay (EMSA). The concentration of the DNA was maintained constant while the concentration of BlcR was increased gradually from 0 to 1 µM (Figure 3).
 +
<p/>
 +
 
 +
<figure>
 +
<a href="https://static.igem.wiki/teams/4361/wiki/results/emsa-blcr-emsa-housestyle.png"><img src="https://static.igem.wiki/teams/4361/wiki/results/emsa-blcr-emsa-housestyle.png" style="width:500px;margin-left:175px"></a>
 +
<figcaption> <b>Figure 3.</b> EMSA study for the characterization of BlcR binding to the 51 bp Blc operator sequence. The concentration of Cy3 labeled DNA was maintained at 25 nM. Titration of dimeric BlcR from lane 1 to 10 . 1: 0μM, 2: 0.1μM, 3: 0.25μM, 4: 0.4μM, 5: 0.5μM, 6: 0.6μM, 7: 0.7μM, 8: 0.8μM, 9: 0.9μM, 10: 1μM.</figcaption>
 +
</figure>  
 +
 
 +
<p>
 +
We successfully validated binding of BlcR to the Blc operator sequence. From the results of EMSA we determined the binding affinity of BlcR to the Blc operator sequence, and established the degree of cooperative binding, expressed in the hill coefficient. We found a binding affinity of 390 nM, together with a hill coefficient of 1.79. These values were not far from what is currently reported in literature. Earlier research of Pan et al. reported a binding affinity of 490 nM [1]. The 1.79 hill coefficient was further on used in modeling experiments. Read more about how we calculated the Kd and the hill coefficient in our<a href='https://2022.igem.wiki/tudelft/model'>model section</a>.
 +
<p/>
 +
 
 +
<p>
 +
Another EMSA study was performed to characterize the dissociation of BlcR from the <i> blc <i/> operator in presence of SSA. We performed an EMSA study where we kept the concentration of BlcR and DNA constant at 1.6 µM and 25 nM respectively, and titrated the concentration of SSA in a range from 0 to 1 mM (<b>Figure 4<b/>). With this study we successfully established the full dissociation of BlcR in presence of > 40 µM SSA.
 +
<p/>
 +
 
 +
<figure>
 +
<a href="https://static.igem.wiki/teams/4361/wiki/results/emsa-ssa-emsa-house-style.png"><img src="https://static.igem.wiki/teams/4361/wiki/results/emsa-ssa-emsa-house-style.png" style="width:500px;margin-left:175px"></a>
 +
<figcaption> <b>Figure 4.</b> EMSA study for the characterization of BlcR dissociating from to the 51 bp Blc operator sequence in presence of SSA. The concentration of Cy3 labeled DNA and BlcR was maintained at 25 nM and 1.6 μM respectively. Titration of SSA from lane 1 to 9 . 1: 0, 2: 64 nM, 3: 320 nM, 4: 1.6 μM , 5: 08 μM, 6: 40 μM, 7: 0.2 mM, 8: 1mM, 9: 25 nM DNA only.</figcaption
 +
</figure>
 +
 
 +
 
 +
 
 +
 
  
 
<!-- Uncomment this to enable Functional Parameter display  
 
<!-- Uncomment this to enable Functional Parameter display  

Revision as of 11:22, 12 October 2022


BlcR with 6xHis-tag and TEV protease cleavage site

BlcR is a transcription factor originating from the bacterium Agrobacterium tumefaciens. A single BlcR monomer contains an effector binding domain near the C-terminus which recognizes the effectors, succinic semialdehyde (SSA) and gamma-Butyrolactone GBL, but also the rape drug gamma-hydroxybutyric acid (GHB). The N-terminal region allows for the dimerization of two BlcR monomers. Dimeric BlcR can bind to the blc operator sequence.
BlcR was originally added to the Parts Registry as Part:BBa_K1758370 by the Bielefeld-CeBiTec iGEM 2015 team. Their sequence for BlcR has been codon optimized for expression in E.coli by us to improve expression of the protein (Part:BBa_K4361100). This composite part consists of codon-optimized BlcR, a 6xHis-tag for purification Part:BBa_K4361102, and a TEV cleavage site for removal of the tag from the protein (Part:BBa_K4361102). With this composite part, we were able to effectively produce and purify BlcR in E. coli .


Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 766
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal BamHI site found at 901
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 150
  • 1000
    INCOMPATIBLE WITH RFC[1000]
    Illegal SapI.rc site found at 661

Usage and biology

BlcR is an allosteric transcription factor BlcR from the bacterium Agrobacterium tumefaciens. This plant bacterium is able to use GBL, a precursor of GHB, as an energy source. In the absence of GBL, GHB or SSA, BlcR will bind to the blc operator sequence Part:BBa_K4361000 and acts as a repressor for the transcription of the blc proteins. When GBL, GHB or SSA binds to BlcR, it is released from the DNA and the blcA, blcB and blcC proteins are transcribed and digest GBL to succinate ( Figure 1 ).

Figure 1. The regulatory mechanism of BlcR on the blc operon and the pathway from gamma-butyrolactone to succinic acid of Agrobacterium tumefaciens.

In our project we have designed a novel bioelectronic sensor for the detection of GHB in drinks by combining the specificity of the BlcR regulatory mechanism with the reliability of electronics. BlcR is tethered by dsDNA oligonucleotides carrying the blc operator sequence Part:BBa_K4361000 to the surface of a gold interdigitated electrode (IDE). We can measure the capacitance of the IDE, which is influenced by the protein molecules around the fingers of the electrode. If GHB enters the system, it will bind to BlcR, which will then release from the electrode causing the capacitance to increase. Electronic hardware will interpret the change in capacitance and produce an output signal to warn the user that their drink has been spiked.

Experimental results

Wet Lab module 1 focused on optimizing the expression and purification of BlcR. After applying the engineering cycle multiple times, a protocol was developed which allowed for effective protein production and purification. After expression in E. coli BL21(DE3) cells, the protein was purified with Ni-NTA column purification and gel filtration.
We were able to obtain a highly pure and concentrated (36.1 µM) BlcR sample after executing our optimized production and purification (Figure 2).
Figure 2. SDS PAGE of different elution fractions after size exclusion with BlcR protein sample. Protein bands corresponding to the monomer (~35 kDa) and dimer (~70 kDa) of BlcR are visible.

To characterize the binding of BlcR to its cognate DNA binding sequence [[Part:BBa_K4361000]], we used electrophoresis mobility assay (EMSA). The concentration of the DNA was maintained constant while the concentration of BlcR was increased gradually from 0 to 1 µM (Figure 3).

Figure 3. EMSA study for the characterization of BlcR binding to the 51 bp Blc operator sequence. The concentration of Cy3 labeled DNA was maintained at 25 nM. Titration of dimeric BlcR from lane 1 to 10 . 1: 0μM, 2: 0.1μM, 3: 0.25μM, 4: 0.4μM, 5: 0.5μM, 6: 0.6μM, 7: 0.7μM, 8: 0.8μM, 9: 0.9μM, 10: 1μM.

We successfully validated binding of BlcR to the Blc operator sequence. From the results of EMSA we determined the binding affinity of BlcR to the Blc operator sequence, and established the degree of cooperative binding, expressed in the hill coefficient. We found a binding affinity of 390 nM, together with a hill coefficient of 1.79. These values were not far from what is currently reported in literature. Earlier research of Pan et al. reported a binding affinity of 490 nM [1]. The 1.79 hill coefficient was further on used in modeling experiments. Read more about how we calculated the Kd and the hill coefficient in ourmodel section.

Another EMSA study was performed to characterize the dissociation of BlcR from the blc operator in presence of SSA. We performed an EMSA study where we kept the concentration of BlcR and DNA constant at 1.6 µM and 25 nM respectively, and titrated the concentration of SSA in a range from 0 to 1 mM (Figure 4). With this study we successfully established the full dissociation of BlcR in presence of > 40 µM SSA.

Figure 4. EMSA study for the characterization of BlcR dissociating from to the 51 bp Blc operator sequence in presence of SSA. The concentration of Cy3 labeled DNA and BlcR was maintained at 25 nM and 1.6 μM respectively. Titration of SSA from lane 1 to 9 . 1: 0, 2: 64 nM, 3: 320 nM, 4: 1.6 μM , 5: 08 μM, 6: 40 μM, 7: 0.2 mM, 8: 1mM, 9: 25 nM DNA only.